Jeff Miller v. Tema Isenmann, Inc.

Kentucky Supreme Court·Decided March 22, 2018·No. 2016-SC-0449·Unpublished

Opinion

RENDERED:. MARCH 22, 2018

·~~nE~U~H[

fouptttut ~Inurf of ~t!JlUmf\l_J ~ . 2016-SC-000449-WC

[Q) ~~ ~1/12{18 J<,,;, f2¥.t\, I>~ JEFF MILLER APPELLANT

ON REVIEW FROM COURT OF APPEALS V. CASE NO. 2015-CA-001544-WC DEPARTMENT OF WORKERS' CLAIMS NO. 2012-WC-00400

TEMA ISENMANN, INC., HON. WILLIAM J. APPELLEE RUDLOFF, ADMINISTRATIVE LAW JUDGE AND'woRKERS' COMPENSATION BOARD

OPINION OF THE COURT BY JUSTICE WRIGHT REVERSING

Appellant, Jeff Miller, worked for Appellee, TEMA Isenmann, Inc., for fifteen years. Miller was diagnosed with and treated for bladder cancer, which he asserts stemmed from exposure to a workplace carcinogen. He sought permanent total disability benefits based upon his assertion that his bladder cancer amounted to an occupational disease. The administrative law judge (AW) awarded the benefits Miller sought. TEMA appealed to the Workers' Compensation Board, which vacated and remanded back to the AW. On remand, the AW awarded the same benefits and the Board vacated and remanded yet again. On TEMA's third appeal, however, the Board affirmed the AW. TEMA appealed the Board's decision to the Court of Appeals, which reversed. Miller appeals that decision to this Court as a matter of right. See

(

Vessels v. Brown-Fonnan Distillers Corp., 793 S.W.2d 795, 798 (Ky. 1990); Ky. Const.§ '115.

I. BACKGROUND

TEMA is a German-owned, multi-national company that produces

industrial screens. Miller worked for TEMA from 1995 until 2010 as a purchasing agent. Though he was not involved in the actual production process, Miller's office door opened into the plant. Miller's job duties required him to enter the production floor daily to check the inventory. He claims that MOCA, a curing agent, was airborne in the plant.

MOCA was used by TEMA in its production facility during Miller's tenure (though the company has since stopped using the agent, as the Occupational Safety and Health Administration ordered TEMA to make costly changes to its operations to continue using MOCA). MOCA is scien,tifically proven to cause cancer in animals and is highly suspected of being a human carcinogen as . well. Testimony from a T;EMA plant manager described the "closed system" which was in place on the production floor when Miller retired. In this closed system, MOCA was never open to the air and employee exposure is limited. However, Miller and the TEMA manager both testified that this system was only in place from around 2005 onward (only for approximately the last five years of Miller's fifteen-year tenure with the company).

Prior to implementation of the closed system, TEMA employees added MOCA to the production process manually via an older open-air machine. In using that system, production workers removed bags of MOCA pellets from cardboard drums, cut the bags open with carpenter's knives, and manually poured the MOCA pellets into the machine. This process is how Miller believes

MOCA became airborne in the plant, thus leading to his exposure. TEMA denies that MOCA was ever airborne in the production facility and conten,<ls that the facility boasts a favorable record for the safety and health of its· employees·:

TEMA monitored workers for MOCA exposure.by testing employees'

urine ..Specifically, the company tested production employees-but never office employees-for exposure once every three months. W~en a production plant employee tested positive for MOCA exposure, TEMA altered.. the employee's job duties until MOCA was no longer present in the employee's urine. Because Miller was an office employee, TEMA never tested him for MOCA exposure. However, Miller testified that two to three production employees usually tested positive for MOCA each time TEMA tested employees' urine. The TEMA' plant

manager testified. that he has managed the plant since 2001,

l

and that in that

time only two to three employees ever· tested positive for MOCA exposure. At any rate, whether the number was two to three every three months or two to· three total, it is undisputed that some number of employees tested positive for MOCA exposure.

In 2010, Miller retired from TEMA. Later that same year, doctors dl.agnosed hi~ with bladder cancer. Miller's cancer required the removal of his bladder, radiatioIJ., and chemotherapy. On March 29, 2012, Miller filed an Application for Resolution of Occupational Disease Claim, alleging that his

cancer was caused by MOCA exposure during his employment with TEMA. · On September 13, 2012, the AW rendered an opinion determining that Miller's bladder cancer was causally related to workplace exposure to MOCA and awarded permanent total disability.and medical benefits. TEMA moved the AW to order a university medical evaluation pursuant to KRS 342.315, but the AW denied that motion.

TEMA ap~ealed to the Board, arguing that the ALJ's finding that Miller's bladder cancer was caused by expo.sure to. MOCA was not supported by subst.antial evidence and that the AW erred by refusing to order a university medical evaluation. Concluding that university evaluations are mandatory in occupational disease claims, the Board vacated the AW's order and remanded the case, ordering the, university evaluation to be performed under KRS 342.315 and 342.316(3)(b)(4)(b).

On February 15, 2013, the AW ordered Miller to undergo a university medical evaluation to be scheduled by the Department of Workers' Claims (DWC). Six days later, the AW entered a follow-up order advising the parties that the DWC had informed him "that there [we]re :no university evaluators

available for this case at either the University of Kentucky or the University of ' , r

. Louisville," and that "[f]or that reason, a university evaluation [wa]s not possible." The AW thus ordered the parties to confer and agree on an · independent medic'al evaluator .. Both parties objected to the opinion of a

physician who was not a university employee being given presumptive weight under the statutes.

Still, the AW ordered both parties to produce three names of willing physicians from which the AW would choose an evaluator. Miller produced three options, though none of the doctors were oncologists. TEMA asked for an extension of time to continue searching for qualified doctors willing to participate, noting a lack of expertise in cancer diagnosis and treatment among the proposed. field of candidates. The AW denied TEMA's request and chose one of the physicians offered by Miller, Dr. David Jackson, a physical- medicine-and-rehabilitation physician.

Dr. Jackson completed his evaluation, and assigned Miller a fifty-eight percent impairment rating pursuant to AMA guidelines. However, Dr. Jackson stated that he had no opinion as to the cause of Miller's cancer. The AW again entered an opinion finding that Miller's bladder cancer was caused by exposure to MOCA through his employment with TEMA and awarded permanent total disability and medical benefits.

TEMA appeale~ this decision to the Board, and the Board once again vacated and remanded the case to the AW. In doing so, the Board first ruled that the AW's assertions as to the unavailability of university evaluators lacked sufficient support in the record. The Board required the AW to file correspondence from the DWC "memorializ[ing], with specificity, the

I

availability, or lack thereof, of university evaluators in this litigation." The

Board then added that even if no university evaluator was willing to participate,

I

the mandatory langu~ge ofKRS 342.316(3)(b)(4)(b) requires the Commissioner to choose a physician to perform the evaluation. It held the AW abused his discretion by not "request[ing] the Commissioner to choose a physician who will act in place of the university evaluator."

Free access — add to your briefcase to read the full text and ask questions with AI

Jeff Miller v. Tema Isenmann, Inc., (Ky. 2018).

Jeff Miller v. Tema Isenmann, Inc. (Jeff Miller v. Tema Isenmann, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Knotts v. Zurich Insurance Co.
197 S.W.3d 512 (Kentucky Supreme Court, 2006)
Lewis v. Jackson Energy Cooperative Corp.
189 S.W.3d 87 (Kentucky Supreme Court, 2005)
Ira A. Watson Department Store v. Hamilton
34 S.W.3d 48 (Kentucky Supreme Court, 2000)
Whittaker v. Rowland
998 S.W.2d 479 (Kentucky Supreme Court, 1999)
Smyzer v. BF Goodrich Chemical Company
474 S.W.2d 367 (Court of Appeals of Kentucky (pre-1976), 1971)
Osborne v. Commonwealth
185 S.W.3d 645 (Kentucky Supreme Court, 2006)
Paramount Foods, Inc. v. Burkhardt
695 S.W.2d 418 (Kentucky Supreme Court, 1985)
Stephenson v. Woodward
182 S.W.3d 162 (Kentucky Supreme Court, 2006)
Bowerman v. Black Equipment Co.
297 S.W.3d 858 (Court of Appeals of Kentucky, 2009)
Morrison v. Home Depot
279 S.W.3d 172 (Court of Appeals of Kentucky, 2009)
Vessels Ex Rel. Vessels v. Brown-Forman Distillers Corp.
793 S.W.2d 795 (Kentucky Supreme Court, 1990)
Miller v. East Kentucky Beverage/Pepsico, Inc.
951 S.W.2d 329 (Kentucky Supreme Court, 1997)
Layne v. Newberg
841 S.W.2d 181 (Kentucky Supreme Court, 1992)
Abel Verdon Construction v. Rivera
348 S.W.3d 749 (Kentucky Supreme Court, 2011)
Shawnee Telecom Resources, Inc. v. Brown
354 S.W.3d 542 (Kentucky Supreme Court, 2011)